/Methods And Compositions Using Rna Interference And Antisense Oligonucleotides For Inhibition Of Kras
Abstract

The invention relates to the inhibition of expression of mutant KRAS sequences using RNA interference, antisense oligonucleotides, and chemically-modified oligonucleotides.

Full Text

What is claimed is:

The invention relates to the inhibition of expression of mutant KRAS sequences using RNA interference, antisense oligonucleotides, and chemically-modified oligonucleotides.
Timeline
Filed
03/27/2026
Published
07/23/2026
Granted
Not Available
IPC Codes(2)
C12N 15/113:Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
A61P 35/00:Antineoplastic agents